Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1993 Dec;119(12):702–706. doi: 10.1007/BF01195340

Chemotherapeutic effect on osteosarcoma on basis of collagen analysis: A proposal of the induction of osteosarcoma differentiation

H Tsuchiya 1,✉, Y Ueda 2, K Tomita 1, I Nakanishi 2, A Roessner 3
PMCID: PMC12200697  PMID: 8408182

Abstract

The authors studied effect of chemotherapy on osteosarcoma by collagen analysis. As a result of this case study we propose the induction of osteosarcoma differentiation by chemotherapy. Treatment of a conventional osteosarcoma with two intra-arterial infusions of cisplatin and the T-12 protocol of Rosen resulted in sclerotic changes and good margination accompanied by the disappearance of the soft-tissue component from the X-rays. More than 90% tumour destruction was histologically demonstrated; tumour bone and osteoid increased after the chemotherapy, and the viable area of the tumour resembled an osteoblastoma. Before the chemotherapy, immunolocalization determined collagen types I and V to be diffusely present in the bone and osteoid. After the chemotherapy, the antibody to type I collagen was diffusely present, but the antibody to type V collagen occurred only on the surface of the increased bone and osteoid as in normal bone. When osteosarcoma cells were treated in vitro with methotrexate or cisplatin, collagen production increased significantly. It is thus believed that tumour cells were directly stimulated with these chemotherapeutic agents to produce collagen. The findings suggested that some anticancer agents might not only be cytotoxic to but also differentiate osteosarcoma cells.

Key words: Osteosarcoma, Chemotherapy, Collagen analysis, Differentiation

References

  1. Brosjo O, Bauer HCF, Brostrom LA, Nilsson OS, Reinholt FP, Tribukait B (1987) Growth inhibition of human osteosarcoma in nude mice by human interferon-alpha: significance of dose and tumor differentiation. Cancer Res 27:258–262 [PubMed] [Google Scholar]
  2. Dahlin DC, Unni KK (1986) Bone tumors. General aspects and data on 8542 cases, 4th edn. Thomas, Springfield, Ill [Google Scholar]
  3. Enneking WF (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106–120 [PubMed] [Google Scholar]
  4. Enneking WF (1986) A system of staging musculoskeletal neoplasms. Clin Orthop 204:9–24 [PubMed] [Google Scholar]
  5. Hsu SM, Raine L, Fanger H (1981) A comparative study of the peroxidase-antiperoxidase method and avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibody. Am J Clin Pathol 75:734–738 [DOI] [PubMed] [Google Scholar]
  6. Junqueira LCU, Assis Figueiredo MT, Torloni H, Montes GS (1986) Differential histologic diagnosis of osteoid: a study on human osteosarcoma collagen by the histochemical picrosiriuspolarization method. J Pathol 148:189–196 [DOI] [PubMed] [Google Scholar]
  7. Lollini PL, Giovanni CD, Re BD, Landuzzi L, Nicoletti G, Prodi G, Scotlandi K, Nanni P (1989) Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs. Cancer Res 49:3631–3636 [PubMed] [Google Scholar]
  8. Marroum MC, Huvos AG, Rosen G (1977) Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases. Oncology 34:273–280 [DOI] [PubMed] [Google Scholar]
  9. Minamoto T, Arai K, Hirakawa S, Nagai Y (1987) Immunohistochemical studies on collagen types in the uterine cervix in pregnant and nonpregnant state. Am J Obstet Gynecol 156:138–144 [DOI] [PubMed] [Google Scholar]
  10. Mirra JM (1989) Bone tumors. Clinical, radiologic, and pathologic correlations, 1st edn. Lea & Febiger, Philadelphia, pp 248–389 [Google Scholar]
  11. Molenaar WM, Oosterhuis JW, Kamps WA (1984) Cytologic “differentiation” in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol 15:973–979 [DOI] [PubMed] [Google Scholar]
  12. Murray JA, Jessup K, Romsdahl M, Raymond K, Ayala A, Carrasco H, Wallace S, Jaffe N, Benjamin R, Plager C, Papadopoulos N, Chawala S (1985) Limb-salvage surgery in osteosarcoma: early experience at M.D. Anderson Hospital and Tumor Institute. Cancer Treat Symp 3:131–137 [Google Scholar]
  13. Oda Y, Kawahara E, Minamoto T, Ueda Y, Ikeda K, Nagai Y, Nakanishi I (1988) Immunohistochemical studies on the tissue localization of collagen types I, III, IV, V, and VI in schwannomas. Correlation with ultrastructural features of the extracellular matrix. Virchows Arch [B] 56:153–163 [DOI] [PubMed] [Google Scholar]
  14. Okada Y, Katsuda S, Matsui Y, Watanabe H, Nakanishi I (1990) Collagen synthesis by cultured arterial smooth muscle cells during spontaneous phenotypic modulation. Acta Pathol Jpn 40:157–164 [DOI] [PubMed] [Google Scholar]
  15. Peterkofsky B, Chojkier M, Bateman J (1982) Determination of collagen synthesis in tissue and cell culture system. Immunocytochemistry of the extracellular matrix, vol 2. CRC, Boca Raton, Fla, pp 19–48 [Google Scholar]
  16. Picci P, Bacci G, Campanacci M, Casparini M, Pilotti S, Cerasoli S, Bertoni F, Guerra A, Capanna R, Albissini U, Galletti S, Gherlinzoni F, Calderoni P, Sudanese A, Baldini N, Bernini M, Jaffe N (1985) Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer 56:1515–1521 [DOI] [PubMed] [Google Scholar]
  17. Raymond AK, Chawla SP, Carrasco HC, Ayala AG, Fanning CV, Grice B, Armen T, Plager C, Papadopoulos NEJ, Edeiken J, Wallace S, Jaffe N, Murray JA, Benjamin RS (1987) Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 4:212–236 [PubMed] [Google Scholar]
  18. Rennard SI, Berg R, Martin GR, Foidart JM, Robey PG (1980) Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 104:203–214 [DOI] [PubMed] [Google Scholar]
  19. Roessner A, Voss B, Rauterberg J, Immenkamp M, Grundmann E (1983) Biologic characterization of human bone tumors. II. Distribution of different collagen types in osteosarcoma—a combined histologic, immunofluorescence and electron microscopic study. J Cancer Res Clin Oncol 106:234–239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rosen G (1985) Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a 10-year experience. Orthopedics 8:659–664 [DOI] [PubMed] [Google Scholar]
  21. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230 [DOI] [PubMed] [Google Scholar]
  22. Rosen G, Marcove RC, Huvos AG, Caparros BI, Lane JM, Nirenberg A, Cacavio A, Groshen S (1983) Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol 106:55–67 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tomita K, Yokogawa A, Nomura S (1986) Human tumor clonogenic assay in osteosarcoma for evaluation of clinical efficacy of anti-cancer drugs. Cancer Chemother Pharmacol 18:133–136 [DOI] [PubMed] [Google Scholar]
  24. Tsuchiya H, Tomita K, Yasutake H, Morishita H, Morikawa S, Ohno M, Tsuchida T, Takagi Y, Ueda Y, Terahata S (1990) Histological response to pre-operative chemotherapy and prognosis in osteosarcoma (in Japanese). J Jpn Orthop Assoc 64:S493 [Google Scholar]
  25. Ueda Y, Nakanishi I (1989) Immunohistochemical and biochemical studies on the collagenous proteins of human osteosarcomas. Virchows Arch [B] 58:79–88 [DOI] [PubMed] [Google Scholar]
  26. Ueda Y, Oda Y, Tsuchiya H, Tomita K, Nakanishi I (1990) Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone. Virchows Arch [A] 417:291–297 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES